In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...

The S&P/ASX Small Ordinaries Index (ASX) fell 57.70 points, or 1.73%, yesterday to close at 3,268.80. The index is now down ...

Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and renewed merger activity pulled capital back into a sector that spent much of the ...

Driven by valuation concerns and underperforming returns among top AI stocks, investors are shifting capital towards the ...

The narrative that defined the last three years, where a handful of mega-cap tech giants carried the entire weight of the U.S. economy, is finally beginning to fracture. In the first quarter of 2026, ...

The Russell 2000 Index has surged nearly 22% this year, posting its best first-half performance since 1991. "It's both a valuation catch-up story and a fundamental story," said Amy Zhang, portfolio ...

XBI's equal-weight spread across 100+ biotechs delivered a 73% one-year return, nearly doubling PBE's 35% from its 30-stock, large-cap-anchored portfolio. During the 2021 to 2022 biotech collapse, PBE ...